Product image of Migsun (Naproxen Sodium, Sumatriptan Succinate) supplied by GNH India

Migsun

Active Ingredient:
Naproxen Sodium, Sumatriptan Succinate
Origin:
EU

Migsun (Naproxen Sodium, Sumatriptan Succinate)

Naproxen sodium and sumatriptan succinate, the active ingredients in Migsun, are a NSAID/5‑HT1B/1D agonist combination presented as an oral tablet for oral use. It treats acute migraine attacks in adults.

GNH India supplies Migsun as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Migsun is a combination drug used in the acute migraine pathway to abort headache episodes.

  • Acute migraine attack: provides rapid relief of headache and associated symptoms.
  • Migraine with aura: aborts attacks when taken early in the aura phase.
  • Migraine recurrence: can be used as a second dose if the first dose does not fully control the episode, under medical supervision.

How It Works

  • Naproxen sodium inhibits cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, reducing prostaglandin synthesis and inflammation. Sumatriptan succinate selectively activates 5‑HT1B and 5‑HT1D receptors, causing cranial vasoconstriction and blocking release of pro‑inflammatory neuropeptides, thereby terminating migraine attacks.

Side Effects

Migsun may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Dizziness: transient light‑headedness.
  • Dry mouth: reduced salivation.
  • Abdominal pain: discomfort in the stomach area.
  • Fatigue: feeling unusually tired.
  • Tingling sensation: paresthesia in extremities.

Serious or Rare Side Effects

  • Chest pain: possible cardiac ischemia.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Serotonin syndrome: agitation, hyperthermia, muscle rigidity.
  • Cardiovascular events: stroke or myocardial infarction.
  • Severe liver injury: jaundice, elevated enzymes.
  • Stevens‑Johnson syndrome: serious skin blistering.

Precautions & Warnings

Before prescribing Migsun, clinicians should consider several safety factors.

  • Cardiovascular risk assessment: evaluate patients with coronary artery disease.
  • Hypertension monitoring: avoid use in uncontrolled high blood pressure.
  • Serotonergic drug caution: assess risk of serotonin syndrome when combined with other serotonergic agents.
  • Hypersensitivity screening: do not use in patients allergic to NSAIDs or triptans.
  • Renal function evaluation: adjust or avoid in severe renal impairment.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Migsun can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid)

  • MAO inhibitors: increased risk of serotonin syndrome.
  • Other triptans or ergotamines: risk of severe vasospasm.
  • Potent CYP3A4 inhibitors: may raise sumatriptan plasma levels.
  • Anticoagulants or antiplatelet agents: heightened bleeding risk.

Moderate Interactions (Monitor Closely)

  • NSAIDs with antihypertensives: possible reduction of blood‑pressure control.
  • SSRIs/SNRIs with sumatriptan: monitor for serotonin syndrome signs.
  • Naproxen with lithium: monitor lithium serum concentrations.

Frequently Asked Questions

Migsun is prescribed for the acute treatment of migraine attacks in adults. It combines an NSAID with a triptan to relieve headache pain, reduce associated nausea, and stop the progression of migraine symptoms when taken early in an attack.

Naproxen sodium blocks COX‑1 and COX‑2 enzymes, lowering prostaglandin production and inflammation. Sumatriptan activates 5‑HT1B/1D receptors, causing cranial blood‑vessel constriction and preventing release of neuropeptides that trigger migraine pain, together providing rapid symptom relief.

The specific dose of Migsun is determined by the prescribing clinician based on the patient’s medical history, severity of migraine, and any concomitant medications. Patients should follow the exact dosing instructions provided by their healthcare professional.

Migsun is generally not recommended during pregnancy or while breastfeeding unless the potential benefit outweighs the risk. Both naproxen and sumatriptan cross the placenta and may be excreted in breast milk, so clinicians should evaluate safety on a case‑by‑case basis.

To request Migsun, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Migsun combines an NSAID and a triptan, offering both anti‑inflammatory and vasoconstrictive actions in a single tablet. This can provide faster relief compared with using an NSAID or a triptan alone, and may reduce the need for multiple pills during an attack.

Migsun should be stored at ambient temperature below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Migsun is taken orally, usually with a full glass of water. It is recommended to swallow the tablet whole and not to crush or chew it. The medication should be taken as soon as migraine symptoms begin for optimal effectiveness.

Serious risks include cardiovascular events such as chest pain or heart attack, severe allergic reactions like anaphylaxis, and serotonin syndrome when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience these symptoms.

Migsun should be avoided in individuals with known hypersensitivity to naproxen, other NSAIDs, or sumatriptan; patients with uncontrolled hypertension, recent myocardial infarction, severe coronary artery disease, or those taking MAO inhibitors. A healthcare professional must evaluate suitability before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naproxen Sodium, Sumatriptan Succinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT